MODEL TEMAN APOTEKER: ALTERNATIF MODEL INTERVENSI APOTEKER BAGI PASIEN TUBERKULOSIS
Nanang Munif Yasin(1*), Djoko Wahyono(2), Bambang Sigit Riyanto(3), Ika Puspitasari(4)
(1) Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta
(2) Fakultas Farmasi, Universitas Gadjah Mada, Yogyakarta
(3) RSUP Dr. Sardjito, Yogyakarta
(4) Fakultas Farmasi, Universitas Gadjah Mada
(*) Corresponding Author
Abstract
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Bhardawaj, A., Kumar, R., Dabas, V., and Alam, N. 2012, Assessment and Enhancing Adherence to Treatment Regimen in Tuberculosis Out Patient, Int J Pharm Pharm Sci, 4(3):517-522.
Bosch-Capblanch, X., Abba, K., Prictor, and M., Garner, P. 2007. Contracts between patients and healthcare practitioners for improving patients’ adherence to
treatment, prevention and health promotion activities. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD004808. DOI: 10.1002/14651858.CD004808.pub3.
Case Management Society of America. 2006, Case Management Adherence Guidelines version 2.0; viewed 1 May 2014 <http://www.cmsa.org.prtals/o/pdf/CM AG2.pdf>.
Castro, A.T., Mendes, M., Freitasa, S. and Roxo, P.C. 2015, Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years, Rev Port Pneumol, 21(3):144---150
Centers for Disease Control and Prevention. 2008, Self-Study Modules on Tuberculosis: Module 1-9, Division of Tuberculosis Elimination CDC, Atlanta, Georgia.
Clark, P.M., Karagoz, T., Apikoglu-Rabus, S.,and Izzettin, F.V. 2007, Effect of pharmacistled patient education on adherence to tuberculosis treatment, Am J Health-Syst Pharm, 64:497-506
Departemen Kesehatan Republik Indonesia. 2005, Pharmaceutical Care Untuk Penyakit Tuberkulosis, Jakarta, Departemen Kesehatan Republik Indonesia.
Departemen Kesehatan Republik Indonesia. 2008, Pedoman pelayanan kefarmasian di rumah (home pharmacy care), Jakarta, Departemen Kesehatan Republik Indonesia.
Departemen Kesehatan Republik Indonesia. 2009, Buku Saku Kader Program Penanggulangan TB), Jakarta, Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan Departemen Kesehatan RI
Departemen Kesehatan Republik Indonesia. 2011, Pedoman Nasional Pengendalian Tuberkulosis, Jakarta, Departemen Kesehatan Republik Indonesia.
Esmael, A., Ali, I., Agonafir, M., Desale, A., Yaregal, Z. and Desta, K. 2013, Assessment of Patients’ Knowledge, Attitude, and Practice Regarding Pulmonary Tuberculosis in Eastern Amhara Regional State, Ethiopia: CrossSectional Study; Am. J. Trop. Med. Hyg, 88(4):785–788
Francis, M.T., and Chandrasekaran, K. 2012, Effectiveness of Knowledge Based Approach for the Provement of Patient Adherence and Reducing the Severity of Adverse Drug Reaction in Anti Tubercular Therapy, IJPTP, 3(3):313-317
Government of India and Indian Pharmaceutical Association. 2013, Revised National Tuberculosis Control Programme, Training Module for Community Pharmacist, Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi, India
Gulbay, B.E, Gurkan, O.U., Yıldız, O.A., Onen, Z.P., Erkekol, F.O., Baccıoglu, A, et al. 2006, Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis, Respiratory Medicine, 100:1834-1842.
Harries A., 2004, What are the most common adverse drug events to first-line tuberculosis drugs, and what is the procedure for reintroduction of drugs? in WHO, 2004, Toman’s Tuberculosis Case detection, treatment, and monitoring –questions and answers, WHO, Geneva, pp 152-158
Kanjee, Z., Catterick, K., Moll, A.P., Amico, K.R., and Friedland, G.H. 2011, Tuberculosis infection control in rural South Africa: survey of knowledge, attitude and practice in hospital staff, Journal of Hospital Infection, 79:333-338.
Liam, C.K., Lim, K.H., Wong, C.M.M., Tang, B.G. 1999, Attitudes and knowledge of newly diagnosed tuberculosis patients regarding the disease, and factors affecting treatment compliance, Int J Tuberc Lung Dis, 3(4):300–309
Liu, Q., Abba, K., Alejandria, M.M., Balanag, V.M., Berba, R.P., and Lansang, M.A.D. 2008. 2008, Reminder systems and late patient tracers in the diagnosis and management of tuberculosis, Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD006594. DOI: 10.1002/14651858.CD006594.pub2.
Lutge, E.E., Wiysonge, C.S., Knight, S.E., and Volmink, J. 2012. Material incentives and enablers in the management of tuberculosis, Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD007952. DOI: 10.1002/14651858.CD007952.pub2.
M’Imunya, J.M., Kredo, T., and Volmink, J. 2012, Patient education and counselling for promoting adherence to treatment for tuberculosis (Review), Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD006591. DOI: 10.1002/14651858.CD006591.pub2.
Marra, F., Marra, C.A., Bruchet, N., Richardson, K., Moadebi, S., Elwood, R.K., et al. 2007, Adverse drug reactions associated with first-line anti-tuberculosis drug regimens, Int J Tuberc Lung Dis, 11: 868– 875.
McDonnell, M., Turner, J., and Weaver, M.T. 2001, Antecedents of adherence to antituberculosis therapy, Publib Health Nursing, 18(6):392-400
Medecins Sans Frontieres. 2013, Checklists for Patient education/counselling sessions for those with active TB disease, Including drug-resistant TB, MSF OCB, Georgia.
Minnery, M., Contreras, C., Perez, R., Solorzano, N.,Tintaya, K., Jimenez, J. et al. 2013, A Cross Sectional Study of Knowledge and Attitutes Towards Tuberculosis amongst Front-Line Tuberculosis Personnel in High Burden Areas of Lima, Peru. PloS ONE 8(9):e75698. Doi:10.1371/journal.pone.0075698.
Mitrzyk, B.M. 2008, Treatment of extensively drug-resistant tuberculosis and role of the pharmacist, Pharmacotherapy, 28(10): 1243-1254
Navio, J.L.P., Yuste, M.R. and Pasicatan, M.A. 2002, Socio-economic determinants of knowledge and attitudes about tuberculosis among the general population of Metro Manila, Philippines, Int J Tuberc Lung Dis, 6(4):301–306
Putera, I., Pakasi, A.T., and Karyadi, E. 2015, Knowledge and perception of tuberculosis and the risk to become treatment default among newly diagnosed pulmonary tuberculosis patients treated in primary health care, East Nusa Tenggara: a retrospective study, BMC Res Notes, 8:238
Schaberg, T., Rebhan, K. and Lode, H. 1996, Risk factors for side-effects of isoniazid, Damrifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis, Eur Respir J, 9: 2026–2030.
United States Agency for International Development. 2005, A Trainers Guide for A Workshop On Tuberculosis For Pharmacy Staff in Cambodia, 2005-2011, USAID, Cambodia.
United States Agency for International Development. 2012, Multidrug-resistant tuberculosis: What every patient should know Flipchart Generic, TB CARE II, USAID, US.
Volmink, J. and Garner, P. 2009, Directly observed therapy for treating tuberculosis, The Cochrane Collaboration, 4:1-32
Westerlund, E.E., Tovar, M.A., Lo¨nnermark, E., Montoya, R. And Evans, C.A. 2015, Tuberculosis-related knowledge is associated with patient outcomes in shantytown residents; results from a cohort study, Peru, Journal of Infection, 71: 347-357
World Health Organization (WHO). Adherence to Long-Term Therapies: Evidence for action, Geneva, WHO, 2003
World Health Organization. 2015, Global Tuberkulosis Report 2015, Geneva, WHO.
Wu, P.S., Chou, P., Chang N.T., Sun, W.J., and Kuo, H.S. 2009, Assessment of Changes in Knowledge and Stigmatization Following Tuberculosis Training Workshops in Taiwan, J Formos Med Assoc, 108(5):377-385.
Yasin NM, Wahyono D, Riyanto BS, Sari IP. 2016, Tuberculosis-Related to Knowledge, Adverse Drug Reactions, Clinical Outcome, Adherence in Tuberculosis Patients and Pharmacist Role, A Preliminary Survey for Pharmacist Intervention Model Development. IJPCR, 8(5)Suppl: 517-522
Yee, D., Valiquette, C., Pelletier, M., Parisien, I., Rocher, I. and Menzies, D. 2003, Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis, Am J Respir Crit Care Med, 167: 1472– 1477.
Yew, W.W. 2002, Clinically Significant Interactions with Drugs Used in the Treatment of Tuberculosis, Drug Safety, 25(2):111-133
DOI: https://doi.org/10.22146/jmpf.350
Article Metrics
Abstract views : 3042 | views : 8181Refbacks
- There are currently no refbacks.
Copyright (c) 2016 JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.